David M Ryckman

Discovery of CX-6258. A Potent, Selective, and Orally Efficacious pan-Pim Kinases Inhibitor.

Adam Siddiqui-Jain, J. Bliesath, Diwata Macalino, 2012, ACS medicinal chemistry letters.

Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53.

Carleen Cullinane, Ricky W Johnstone, S. Lowe, 2012, Cancer cell.

Unprecedented selectivity and structural determinants of a new class of protein kinase CK2 inhibitors in clinical trials for the treatment of cancer.

Roberto Battistutta, L. Pinna, R. Battistutta, 2011, Biochemistry.